Not Signed In -
Massage therapy |
|
|
Massage is the practice of applying structured pressure, tension, motion or vibration — manually or with mechanical aids — to the soft tissues of the body, including muscles, connective tissue, tendons, ligaments, joints and lymphatic vessels, to achieve a beneficial response. A form of therapy, massage can be applied to parts of the body or successively to the whole body, to heal injury, relieve psychological stress, manage pain, and improve circulation. Where massage is used for its ph ...
Wikipedia - [full article]
Massage therapy Clinical Trials
- Preterm Infants' Weight Gain Following Massage Therapy
ClinicalTrials.gov Identifier: NCT00029198 - Recruiting
Premature Birth
- A Randomized Study of Polarity or Massage Therapy to Reduce Fatigue in Breast Cancer Patients During Radiation Therapy
ClinicalTrials.gov Identifier: NCT00288795 - Recruiting
Fatigue
- Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00253708 - Active, not recruiting
Cancer
- Home Based Massage and Relaxation for Sickle Cell Pain
ClinicalTrials.gov Identifier: NCT00066079 - Active, not recruiting
Sickle Cell Disease
- Acute Post-Operative Pain Management Using Massage As Adjuvant Therapy
ClinicalTrials.gov Identifier: NCT00057148 - Completed
Pain
- Massage for the Treatment of Cancer-Related Pain
ClinicalTrials.gov Identifier: NCT00082290 - Recruiting
Neoplasms; Pain
- Effect of Massage Therapy on Aggression in a Psychiatric Inpatient Unit
ClinicalTrials.gov Identifier: NCT00421070 - Recruiting
Acute Psychiatric Disorders
- Massage Therapy for Breast Cancer Treatment-Related Swelling of the Arms
ClinicalTrials.gov Identifier: NCT00058851 - Recruiting
Lymphedema
- Massage to Increase Well-Being and Immune Function in Dominican Children Infected With HIV
ClinicalTrials.gov Identifier: NCT00070980 - Completed
HIV Infections; AIDS
- Hypnosis, Massage Therapy, and Healing Touch in Treating Patients Receiving Chemotherapy for Ovarian Epithelial Cancer or Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00293293 - Recruiting
Ovarian Cancer; Peritoneal Cavity Cancer
- Does Scar Massage Improve Postoperative Pain and Function in Women With Breast Cancer?
ClinicalTrials.gov Identifier: NCT00175344 - Active, not recruiting
Breast Cancer
- Effects of Massage on the Immune System of Preterm Infants
ClinicalTrials.gov Identifier: NCT00317278 - Recruiting
Premature Birth; Stress
- Hormone Therapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
adenocarcinoma of the prostate
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
refractory plasma cell neoplasm
- Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
adult brain tumor
- Acupuncture and Massage for Depression During Pregnancy
ClinicalTrials.gov Identifier: NCT00186654 - Recruiting
Major Depressive Disorder (During Pregnancy)
- Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
Head and Neck Cancer
- Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
- Treatment of Depression with Massage in HIV
ClinicalTrials.gov Identifier: NCT00033852 - Completed
Acquired Immunodeficiency Syndrome; HIV Infections; Depression
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
ClinicalTrials.gov Identifier: NCT00033254 - Active, not recruiting
brain metastases
- Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
Head and Neck Cancer
- Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
intraocular melanoma; Melanoma
- Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
- Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00082823 - Active, not recruiting
Cancer
- Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00083213 - Active, not recruiting
Cancer
- Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
- Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
recurrent neuroblastoma
- Enzastaurin in Treating Patients With Recurrent Gliomas
ClinicalTrials.gov Identifier: NCT00112788 - Active, not recruiting
adult brain tumor
- Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00128700 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00182689 - Active, not recruiting
Lung Cancer
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002786 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00045149 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
- Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00096512 - Active, not recruiting
Head and Neck Cancer
- Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/neu-Expressing Cancer
ClinicalTrials.gov Identifier: NCT00084513 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00091299 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
intraocular melanoma; Melanoma
- Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00028678 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
ClinicalTrials.gov Identifier: NCT00006734 - Active, not recruiting
localized tumors of the Ewing's family
- Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
- Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00003456 - Active, not recruiting
adult glioblastoma
- Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00006113 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
intraocular melanoma; Melanoma
- Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
adult non-Hodgkin's lymphoma
- Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
Colon Cancer; Rectal Cancer
- Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
ClinicalTrials.gov Identifier: NCT00003414 - Active, not recruiting
Lymphoma
- Sorafenib in Treating Patients with Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00119249 - Active, not recruiting
Stage IV Melanoma
- GW786034 in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00060151 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
Lymphoma
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
- Combination Chemotherapy in Treating Women With Stage I Breast Cancer
ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
stage I breast cancer
- Brief Strategic Family Therapy for Adolescent Drug Abusers - 1
ClinicalTrials.gov Identifier: NCT00095303 - Active, not recruiting
Behavior Therapy
- Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
ClinicalTrials.gov Identifier: NCT00004227 - Active, not recruiting
Oral Cancer; Throat Cancer
- Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
recurrent prostate cancer; Anemia; Fatigue
- Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
Head and Neck Cancer; thorax and respiratory cancer
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
ClinicalTrials.gov Identifier: NCT00217620 - Active, not recruiting
adult soft tissue sarcoma
- Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
ClinicalTrials.gov Identifier: NCT00003113 - Active, not recruiting
Lymphoma
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
Stage IV Renal Cell Cancer
- Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
adult non-Hodgkin's lymphoma
- Tipifarnib in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00060125 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of the HER2/neu Protein
ClinicalTrials.gov Identifier: NCT00004074 - Active, not recruiting
Cancer
- Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00012233 - Active, not recruiting
Stage IV rectal cancer; stage IV colon cancer
- Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00080873 - Active, not recruiting
Cancer; oral complications of cancer and cancer therapy
- Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126490 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
ClinicalTrials.gov Identifier: NCT00003478 - Active, not recruiting
adult brain tumor
- ZD6474 and Docetaxel in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00054093 - Active, not recruiting
Non-small cell lung cancer
- Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00049296 - Active, not recruiting
Cancer
- SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
ClinicalTrials.gov Identifier: NCT00006247 - Active, not recruiting
Brain Cancer
- Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
ClinicalTrials.gov Identifier: NCT00003484 - Active, not recruiting
Central Nervous System Tumor; Brain Tumor
- Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00054132 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
ClinicalTrials.gov Identifier: NCT00005052 - Active, not recruiting
stage II melanoma
- Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00027729 - Active, not recruiting
recurrent colon cancer; recurrent rectal cancer
- Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00104988 - Active, not recruiting
Stage IV Melanoma
- SU011248 in Treating Women With Metastatic Breast Cancer That Did Not Respond to Anthracycline or Taxane Chemotherapy
ClinicalTrials.gov Identifier: NCT00095615 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00017355 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00009776 - Active, not recruiting
Burkitt's Lymphoma; Lymphocytic Lymphoma
- Thalidomide in Treating Patients With Myelofibrosis
ClinicalTrials.gov Identifier: NCT00015821 - Active, not recruiting
Agnogenic Myeloid Metaplasia
- Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00009763 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016146 - Active, not recruiting
recurrent prostate cancer
- Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00047294 - Active, not recruiting
Mixed Gliomas; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
ClinicalTrials.gov Identifier: NCT00025233 - Active, not recruiting
recurrent cervical cancer; cervical squamous cell carcinoma
- Vaccine Therapy and Interleukin-12 With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00064168 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Lymphocyte Therapy in Treating Patients With Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002589 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00005970 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00009750 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Bevacizumab and Combination Chemotherapy in Treating Patients Who Have Undergone Surgery for Breast Cancer That Has Spread to the Lymph Nodes
ClinicalTrials.gov Identifier: NCT00119262 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; Male Breast Cancer
Resources
- Body work (Wikipedia)
- Massage therapy (Wikipedia)
email this page
print this page
bookmark this page
feedback on this page
